1 January 2018 - The January 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are two major new listings for this month:

• Methylnaltrexone bromide (Relistor) - new medicine
  
• Zoledronic acid monohydrate (Zometa) - new indication
  

Read New Zealand Pharmaceutical Schedule update